Biostem Technologies Inc  

(Public, OTCMKTS:CGAQ)   Watch this stock  
Find more results for PINK:CGAQ
0.0000 (0.00%)
Jan 16 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 4.62M
P/E     -
Div/yield     -
EPS -0.01
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin 28.87% -29.35%
Operating margin 28.87% -29.35%
EBITD margin - -1.87%
Return on average assets 6.20% -12.31%
Return on average equity 9.40% -12.54%
Employees 67 -
CDP Score - -


4749 NE 11th Ave
OAKLAND PARK, FL 33334-3907
United States - Map
+1-954-3808342 (Phone)

Website links


Biostem Technologies, Inc., formerly Caribbean International Holdings, Inc. is in the biotech sector, with assets in the regenerative medicine and anti-aging marketing. The Company is focused to educate, provide and share the benefits of using stem cells and telomere science to promote anti-aging, life extension and defeating disease. The Company has four subsidiaries, which include Regenerative Bioscience; BioStem Farma, Inc., whose primary business is the provision of stem cell therapy treatments; Biostem University, Inc., whose primary business is to educate future administers or providers in its own cell treatment protocols and Biostem Helps, Inc. with its sole purpose to work with non-profit organizations to work with people across the globe to engage in combating illness and disease. The Company offers cell therapies in the areas, such as cardiovascular disease, arthritis, neuropathic pain, peripheral artery disease, sports and body injuries, and stroke.

Officers and directors

Marc Barhonovich President, Chief Executive Officer, Director
Age: 42
Leon F. Willis Jr. Chief Financial Officer, Secretary, Treasurer, Director
Age: 70
Dave Woynarowski Chief Medical Officer
Andrew VanVurst Director
Henry VanVurst Director
Steven Velte Director
Age: 43
Robert Watson Director